Diagnosis of heterozygous familial hypercholesterolaemia in children

International Journal of Clinical Practice

Volumn 62, Issue 7, 2008, Pages 990-994

  Nicholls, D P ^a   Cather, M ^b   Byrne, C ^b   Graham, C A ^b   Young, I S ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; AGE; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENETIC DISORDER; HEALTH SURVEY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX; SIBLING;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, LDL; EARLY DIAGNOSIS; FEMALE; HETEROZYGOTE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; RETROSPECTIVE STUDIES;

EID: 44849089351     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01793.x     Document Type: Article

References (33)

1. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary artery disease in familial hypercholesterolaemia. Br Med J 1991 303 : 893 6.
2. Sorensen KE, Celemajer DS, Georgakopoulos D, Hatcher G, Betteridge DJ, Deanfield JE. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolaemia and is related to the lipoprotein (a) level. J Clin Invest 1994 93 : 50 5.
3. Wiegman A, de Groot E, Hutten BA et al. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 2004 363 : 369 70.
4. Nicholls DP. Familial hypercholesterolaemia in children. Br J Cardiol 2006 13 : 191 4.
5. Leigh SE, Foster AH, Whittall RA, Hubbart CS, Humphries SE. Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolaemia database. Ann Hum Genet 2008 epub ahead of print http://www.ucl.ac.uk/ldlr/Current
6. Varret M, Boileau C, Rabes J-P. The Familial Hypercholesterolemia Website. http://www.umd.necker.fr (accessed October 2005).
7. Graham CA, McIlhatton BP, Kirk CW et al. Genetic screening protocol for familial hypercholesterolaemia which includes splicing defects gives an improved mutation detection rate. Atherosclerosis 2005 182 : 331 40.
8. Department of Health. Our Inheritance, Our Future. London : Department of Health, 2003. http://www.dh.gov.uk/en/publicationsandstatistics
9. Wald DS, Bestwick JP, Wald NJ. Child-parent screening for familial hypercholesterolaemia: screening strategy based on meta-analysis. Br Med J 2007 335 : 599 603.
10. DeMott K, Nhereha L, Humphries SE et al. Clinical Guidelines and Evidence Review for Familial Hypercholesterolaemia: the Identification and Management of Adults and Children with Familial Hypercholesterolaemia. London : National Collaborating Centre for Primary Care and Royal College of General Practitioners, 2008.
11. Leonard JV, Whitelaw AGL, Wolff OH, Lloyd JK, Slack J. Diagnosing familial hypercholesterolaemia in childhood by measuring serum cholesterol. Br Med J 1977 1 : 1566 8.
12. Kwiterovich PO Jr. Identification and treatment of heterozygous familial hypercholesterolemia in children and adolescents. Am J Cardiol 1993 72 : 30D 7D.
13. Ward AJ, O'Kane M, Nicholls DP, Young IS, Nevin NC, Graham CA. A novel single base deletion in the LDLR gene (211delG): effect on serum lipid profiles and the influence of other genetic polymorphisms in the ACE, APOE and APOB genes. Atherosclerosis 1996 120 : 83 91.
14. Vuorio AF, Turtola H, Piilahti K-M, Repo P, Kanninen T, Kontula K. Familial hypercholesterolaemia in the Finnish North Karelia. Arterioscler Thromb Vasc Biol 1997 17 : 3127 38.
15. Friedewald WT, Lewy RI, Frederickson DS. Estimation of concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972 18 : 499 502.
16. Wang J, Ban MR, Hegele RA. Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia. J Lipid Res 2005 46 : 366 72.
17. Wray R, Neil HAW, Rees JAE. Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association. J Roy Coll Phys 1996 30 : 115 8.
18. Frerichs RR, Srinivasan SR, Webber LS, Berenson GS. Serum cholesterol and triglyceride levels in 3,446 children from a biracial community. The Bogalusa Heart Study. Circulation 1976 54 : 302 9.
19. Boulton TJC. The validity of screening for hypercholesterolaemia at different ages from 2 to 17 years. Aust NZ J Med 1979 9 : 542 6.
20. Wiesmann U. Cholesterin-Normalwerte im Kindesalter. Deutsch Med Wochenschr 1994 119 : 1371.
21. O'Donohue JM, Hancock MR, Banerjee GK. Screening for hyperlipidaemia in childhood. J Roy Coll Phys 1996 30 : 268.
22. Committee on Nutrition. Indications for cholesterol testing in children. Pediatrics 1989 83 : 141 2.
23. US Preventative Services Taskforce. Screening for lipid disorders in childhood. Pediatrics 2007 120 : e215 9. http://www.guideline.gov.
24. Graham CA, McLean E, Ward AJM et al. Mutation screening and genotype:phenotype correlation in familial hypercholesterolaemia. Atherosclerosis 1999 147 : 309 16.
25. Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 1999 142 : 105 15.
26. Williams RR, Hunt SC, Schumacher MC, Hegele RA, Leppert MF, Ludwig EH, Hopkins PN. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 1993 72 : 171 6.
27. Report of a WHO Consultation. Familial hypercholesterolaemia (FH). Geneva: World Health Organisation Human Genetics Programme, 1997. http://www.medped.org/who.
28. Wiegman A, Rodenburg J, de Jongh S, Defesche JC, Bakker HD, Kastelein JJ, Sijbrands EJ. Family history and cardiovascular risk in familial hypercholesterolaemia. Circulation 2003 107 : 1473 8.
29. Campagna F, Martino F, Bifolco M et al. Detection of familial hypercholesterolaemia in a cohort of children with hypercholesterolaemia: results of a family and DNA-based screening. Atherosclerosis 2007 (in press).
30. Widhalm K, Dirisamer A, Lindemayr A, Kostner G. Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene. J Inherit Metab Dis 2007 30 : 239 47.
31. Boulton TJ, Craig IH, Hill G. Screening of cord blood low-density-lipoprotein cholesterol in the diagnosis of familial hypercholesterolaemia: a study of 2000 infants. Acta Paediatr Scand 1979 68 : 363 70.
32. Vuorio AF, Turtola H, Kontula K. Neonatal diagnosis of familial hypercholesterolaemia in newborns born to a parent with a molecularly defined heterozygous familial hypercholesterolaemia. Arterioscler Thromb Vasc Biol 1997 17 : 3332 7.
33. Marteau T, Senior V, Humphries SE et al. Psychological impact of genetic testing for familial hypercholesterolemia within a previously aware population: a randomized controlled trial. Am J Med Genet 2004 128A : 285 93.